INAPPROPRIATE UTILIZATION OF ANTICOAGULATION IN PATIENTS WITH ATRIAL FIBRILLATION: THE GLOBAL ANTICOAGULANT REGISTRY IN THE FIELD (GARFIELD) REGISTRY

Guidelines promote risk scores (CHADS2, CHA2DS2-VASc) to aid clinical decision-making. Global real-life data are needed to profile risk and thromboprophylaxis use among newly diagnosed AF patients at risk for stroke. GARFIELD is a global registry of ≥55,000 patients enrolled as 5 sequential